Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes

2022-05-05T18:34:12+00:00April 11th, 2022|

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes Overall Survival CONTACT US Summary This trial investigated the efficacy and safety of this DC-based [...]

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer

2022-04-11T10:07:44+00:00April 11th, 2022|

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer Overall survival CONTACT US Summary The goal of this study was [...]

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

2022-03-23T11:31:15+00:00March 23rd, 2022|

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma Survival time CONTACT US Summary This study evaluated the safety and efficacy [...]

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

2022-03-10T15:05:45+00:00March 10th, 2022|

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma Prospective recurrence-free survival CONTACT US Summary This study investigated the clinical utilization [...]

Phase I/II study of Immunotherapy using Tumor Antigen-pulsed Dendritic Cells in patients with Hepatocellular Carcinoma (HCC)

2022-03-10T14:52:54+00:00March 10th, 2022|

Phase I/II study of Immunotherapy using Tumor Antigen-pulsed Dendritic Cells in patients with Hepatocellular Carcinoma (HCC) Clinical response to DC vaccine CONTACT US Summary This study evaluated the safety, [...]

Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study

2022-01-26T12:49:02+00:00January 26th, 2022|

Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study CT scan CONTACT US Summary This study investigates the effectiveness of adoptive [...]

A randomized controlled trial on patients with or without adjuvant autologous cytokine- induced killer cells after curative resection for hepatocellular carcinoma

2022-01-10T10:24:26+00:00January 10th, 2022|

A randomized controlled trial on patients with or without adjuvant autologous cytokine- induced killer cells after curative resection for hepatocellular carcinoma Overall Survival CONTACT US Summary [...]

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial

2021-12-23T09:01:44+00:00December 23rd, 2021|

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial Clinical Activity CONTACT US Summary In [...]

Go to Top